Exploring the potential of saruparib in overcoming venetoclax resistance in AML

E Jansson - 2024 - lup.lub.lu.se
Acute myeloid leukaemia (AML) is a highly aggressive type of blood cancer. In particular,
elderly and medically unfit patients face a poor prognosis. Treatment with venetoclax and …